Inogen Sets New 12-Month Low at $13.47 (INGN)
Inogen (NASDAQ:INGN) hit a new 52-week low during mid-day trading on Thursday , AnalystRatings.Net reports. The stock traded as low as $13.47 and last traded at $13.81, with a volume of 26,596 shares traded. The stock had previously closed at $14.11.
A number of research firms have recently commented on INGN. Analysts at William Blair initiated coverage on shares of Inogen in a research note on Wednesday, March 12th. They set an “outperform” rating on the stock. Separately, analysts at Leerink Swann initiated coverage on shares of Inogen in a research note on Tuesday, March 11th. They set an “outperform” rating and a $26.00 price target on the stock. Finally, analysts at JPMorgan Chase & Co. initiated coverage on shares of Inogen in a research note on Tuesday, March 11th. They set an “overweight” rating on the stock.
The stock has a 50-day moving average of $16.45 and a 200-day moving average of $16.83. The company has a market cap of $265.1 million and a price-to-earnings ratio of 20.72.
Inogen (NASDAQ:INGN) last announced its earnings results on Thursday, March 27th. The company reported $0.89 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.02 by $0.87. The company had revenue of $19.76 million for the quarter, compared to the consensus estimate of $18.71 million. During the same quarter in the previous year, the company posted ($0.47) earnings per share. The company’s revenue for the quarter was up 42.8% on a year-over-year basis. Analysts expect that Inogen will post $0.23 EPS for the current fiscal year.
Inogen, Inc (NASDAQ:INGN) is a medical technology company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.